Artificial Intelligence in Life Science Market, By Offering (Software (algorithms, AI-powered platforms, modules, etc.), Hardware (compute infrastructure, specialized sensors, imaging devices, etc.), and Services (consulting, integration, training, maintenance, etc.)), By Deployment Model (Cloud Based and On-premise), By Analytics (Descriptive/Reporting, Predictive, Prescriptive/Decision support, and Generative/Synthetic data/AI-driven molecule generation), By Application (Drug Discovery and Development, Clinical Trials Design and Optimization, Medical Diagnosis and Imaging/Biomarker Detection, Precision and Personalized Medicine, Biotechnology/Bioprocessing/Omics, Patient Monitoring and Real-World Evidence (RWE), and Regulatory/Safety and Pharmacovigilance), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs)/Clinical Research Firms, Medical Device Manufacturers, Academic and Research Institutions, Healthcare Providers (Hospitals/Diagnostic Clinics), and Regulatory Agencies and Safety Boards), By Enabling Technology (Machine Learning/Statistical Models, Natural Language Processing (NLP)/Text Mining, Computer Vision/Imaging AI, Deep Learning/Neural Networks, and Hybrid and Multi-modal AI(fusion of modalities)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)